Dopamine modulating agents alter individual subdomains of motivation-related behavior assessed by touchscreen

Olga Babaev1, Hugo Cruces-Solis1, Roberto Arban1

  • 1Central Nervous System Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany.

Neuropharmacology
|April 10, 2022
PubMed